Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Capital Expenditures (2017 - 2024)

MedWellAI (MWAI) has disclosed Capital Expenditures for 8 consecutive years, with $2242.0 as the latest value for Q4 2024.

  • Quarterly Capital Expenditures rose 28.85% to $2242.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2242.0 through Jun 2025, changed N/A year-over-year, with the annual reading at $2242.0 for FY2025, N/A changed from the prior year.
  • Capital Expenditures for Q4 2024 was $2242.0 at MedWellAI, up from -$1740.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $2.4 million in Q2 2023, with the low at -$1740.0 in Q2 2024.
  • Average Capital Expenditures over 5 years is $480019.8, with a median of $33396.5 recorded in 2022.
  • The sharpest move saw Capital Expenditures soared 10916.33% in 2021, then tumbled 100.07% in 2024.
  • Over 5 years, Capital Expenditures stood at $171605.0 in 2020, then crashed by 96.05% to $6782.0 in 2021, then skyrocketed by 563.52% to $45000.0 in 2022, then crashed by 96.13% to $1740.0 in 2023, then grew by 28.85% to $2242.0 in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $2242.0, -$1740.0, and $1740.0 for Q4 2024, Q2 2024, and Q4 2023 respectively.